| |
| |
|
| Insider
Information: |
Greer R Scott |
| Relationship: |
Director |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
745,685 |
|
|
Indirect Shares
|
29,703 |
|
|
| Direct
Value |
$1,114,267 |
|
|
|
Indirect Value
|
$256,634 |
|
|
| Total
Shares |
775,388 |
|
|
| Total
Value |
$1,370,901 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CV Therapeutics Inc |
CVTX |
Director |
2003-12-12 |
18,000 |
2003-12-12 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2022-09-16 |
303,574 |
|
0 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
290,183 |
|
0 |
Premium* |
|
|
Auspex Pharmaceuticals, Inc. |
ASPX |
Director |
2015-05-05 |
0 |
|
0 |
Premium* |
|
|
Sientra, Inc. |
SIEN |
Director |
2018-06-05 |
58,773 |
|
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
44,380 |
|
0 |
Premium* |
|
|
Inogen Inc |
INGN |
Director |
2021-05-10 |
30,775 |
2021-05-10 |
29,703 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ASPX |
Auspex Pharmaceuticals, I... |
Director |
– • – |
2014-07-16 |
4 |
B |
$19.25 |
$99,908 |
D/D |
5,190 |
7,190 |
2.39 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2018-06-05 |
4 |
A |
$20.44 |
$125,011 |
D/D |
6,116 |
58,773 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-07-09 |
4 |
AS |
$25.00 |
$375,225 |
D/D |
(15,009) |
176,574 |
0 |
% |
|
| INGN |
Inogen Inc |
Director |
– • – |
2021-02-03 |
4 |
OE |
$43.21 |
$896,998 |
D/D |
20,000 |
28,021 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-06 |
4 |
AS |
$60.00 |
$516,000 |
D/D |
(8,600) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-04 |
4 |
AS |
$61.99 |
$86,786 |
D/D |
(1,400) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-04 |
4 |
AS |
$67.39 |
$673,900 |
D/D |
(10,000) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-04-06 |
4 |
AS |
$92.22 |
$2,766,600 |
D/D |
(30,000) |
130,333 |
0 |
- |
|
58 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
